S. Kiertscher

发表

Modifying adenoviral vectors for use as gene-based cancer vaccines.

M. Roth, A. Harui, S. Basak, 2004, Viral immunology.

Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes.

M. Roth, S. Swisher, E. Holmes, 1993, American journal of respiratory cell and molecular biology.

Modulation of the Host Response to a Wealthy Immunogenic Murine Tumor by Interleukin-1

S. Kiertscher, 1990 .

Reconstitution of huPBL-NSG Mice with Donor-Matched Dendritic Cells Enables Antigen-Specific T-cell Activation

M. Roth, A. Harui, S. Kiertscher, 2010, Journal of Neuroimmune Pharmacology.

Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells1

S. Dubinett, Michael Roth, Jie Luo, 2000, The Journal of Immunology.

Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.

A. N. Park, M. Roth, R. Figlin, 2000, Cancer research.

Granulocyte Macrophage Colony-stimulating Factor and Interleukin 4 Enhance the Number and Antigen-presenting Activity of Circulating CD 14 1 and CD 83 1 Cells in Cancer Patients 1

A. N. Park, M. Roth, R. Figlin, 2000 .

Dendritic Cells Early Apoptosis of Monocyte-Derived Tumors Promote Altered Maturation and

M. Roth, S. Dubinett, Jie Luo, 2000 .

A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers

M. Roth, P. Gangalum, D. Tashkin, 2018, Journal of Neuroimmune Pharmacology.

Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes

M. Roth, Michael Roth, A. Harui, 2013, Journal of Neuroimmune Pharmacology.

Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation

M. Roth, S. Kiertscher, J. Castaneda, 2015, Journal of Neuroimmune Pharmacology.

Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.

M. Roth, R. Figlin, C. Tso, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dendritic Cells Triggers Induction of IL-12, Activation of Toll-Like Receptor 2 on Human

M. Roth, P. Godowski, K. Miyake, 2013 .

Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL

M. Roth, K. Mitani, A. Harui, 2004, Gene Therapy.

Cell Maturation Via Toll-Like Receptor 2 Microbial Lipopeptides Stimulate Dendritic

M. Roth, P. Godowski, M. Norgard, 2001 .

Human thymocyte responsiveness to stem cell factor: synergy with interleukin-2 for the generation of NK/LAK cytotoxicity.

K. Zsebo, L. Clement, C. Uittenbogaart, 1996, Immunology letters.

Phase I Trial of Granulocyte Macrophage-Colony Stimulating Factor and Interleukin-4 as a Combined Immunotherapy for Patients With Cancer

M. Roth, R. Figlin, B. Gitlitz, 2003, Journal of immunotherapy.

Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1

M. Roth, Qingwen Cheng, K. Mitani, 2002, The Journal of Immunology.

Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1

M. Roth, Qingwen Cheng, K. Mitani, 2002, The Journal of Immunology.

Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation

M. Roth, S. Kiertscher, J. Castaneda, 2015, Journal of Neuroimmune Pharmacology.

Granulocyte/macrophage‐colony stimulating factor and interleukin‐4 expand and activate type‐1 dendritic cells (DC1) when administered in vivo to cancer patients

M. Roth, R. Figlin, B. Gitlitz, 2003, International journal of cancer.

Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 21

P. Godowski, M. Norgard, R. Modlin, 2001, The Journal of Immunology.

Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

M. Roth, Qingwen Cheng, D. Tashkin, 2002, Journal of Neuroimmunology.

Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

Timothy F. Cloughesy, Robert M. Prins, M. Roth, 2005, Clinical Cancer Research.

Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

A. N. Park, R. Paquette, J. Glaspy, 1998, Journal of leukocyte biology.

Human CD14+ leukocytes acquire the phenotype and function of antigen‐presenting dendritic cells when cultured in GM‐CSF and IL‐4

Michael D. Roth, S. Kiertscher, 1996, Journal of leukocyte biology.

Activation of Toll-Like Receptor 2 on Human Dendritic Cells Triggers Induction of IL-12, But Not IL-101

P. Godowski, K. Miyake, M. Norgard, 2000, The Journal of Immunology.

A comparison of gene transfer methods in human dendritic cells.

M. Roth, L. Butterfield, W. McBride, 1997, Cancer gene therapy.

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells.

M. Roth, Qingwen Cheng, D. Tashkin, 2002, Journal of neuroimmunology.

Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells.

M. Roth, J. Belperio, R. Stripecke, 2008, Toxicology and applied pharmacology.

Systemic IL-1 and adjuvant treatment of an experimental tumor

H. Mathews, R. Hornung, S. Kiertscher, 1992, Biotherapy.

Systemic IL-1 and adjuvant treatment of an experimental tumor

H. Mathews, S. Kiertscher, 1992, Biotherapy.

Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes

M. Roth, A. Harui, S. Kiertscher, 2013, Journal of Neuroimmune Pharmacology.

Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.

M. Roth, W. McBride, S. Dubinett, 1996, Cancer gene therapy.

Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells

A. N. Park, R. Paquette, J. Glaspy, 1998, Journal of leukocyte biology.